Clinical trial

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

NCT03860987

Study summary

ClinicalTrials.gov

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record goserelin Normalized identity: goserelin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Enzalutamide Normalized identity: enzalutamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Abiraterone Normalized identity: abiraterone View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 18F-DCFPyL Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Prednisone Normalized identity: prednisone View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Radical Prostatectomy Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-30

PhasePHASE2

Conditions

Castrate Sensitive Prostate Cancerunresolved

Interventions

goserelinDRUG · verified · RxNorm: goserelin

EnzalutamideDRUG · verified · RxNorm: enzalutamide

AbirateroneDRUG · verified · RxNorm: abiraterone

18F-DCFPyLDRUG

PrednisoneDRUG · verified · RxNorm: prednisone

Radical ProstatectomyPROCEDURE

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03860987 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.